41 related articles for article (PubMed ID: 26150475)
1. MicroRNA-150 inhibitors enhance cell apoptosis of melanoma by targeting PDCD4.
Wan J; Yang J; Huang Y; Deng L
Oncol Lett; 2018 Feb; 15(2):1475-1482. PubMed ID: 29434838
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomics analysis of LINC02202/XBP1 axis in melanoma: Implications for drug targeting and PD-1 monoclonal antibody efficacy.
Shang Y; Yang H; Cui J; Wang L; Wang L; Wang Y; Zhao MM; Yu PY; Qiao H; Yang WJ
J Cell Mol Med; 2024 Apr; 28(8):e18247. PubMed ID: 38520212
[TBL] [Abstract][Full Text] [Related]
3. miRNA oligonucleotide and sponge for miRNA-21 inhibition mediated by PEI-PLL in breast cancer therapy.
Gao S; Tian H; Guo Y; Li Y; Guo Z; Zhu X; Chen X
Acta Biomater; 2015 Oct; 25():184-93. PubMed ID: 26169933
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.
Jiang Y; Gao Q; Wang L; Guo C; Zhu F; Wang B; Wang Q; Gao F; Chen Y; Zhang L
Cell Mol Immunol; 2016 Jul; 13(4):524-34. PubMed ID: 26166769
[TBL] [Abstract][Full Text] [Related]
5. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
6. Non-coding RNAs in skin cancers:Biological roles and molecular mechanisms.
Liu F; Li S
Front Pharmacol; 2022; 13():934396. PubMed ID: 36034860
[TBL] [Abstract][Full Text] [Related]
7. Interplay Between Non-Coding RNAs and Programmed Cell Death Proteins.
Ghafouri-Fard S; Hussen BM; Mohaqiq M; Shoorei H; Baniahmad A; Taheri M; Jamali E
Front Oncol; 2022; 12():808475. PubMed ID: 35402235
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.
Ghafouri-Fard S; Gholipour M; Taheri M
Front Oncol; 2021; 11():608987. PubMed ID: 33968718
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells.
Tran TT; Rane CK; Zito CR; Weiss SA; Jessel S; Lucca L; Lu BY; Oria VO; Adeniran A; Chiang VL; Omay SB; Hafler DA; Kluger HM; Jilaveanu LB
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801444
[TBL] [Abstract][Full Text] [Related]
10. Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy.
Gerloff D; Sunderkötter C; Wohlrab J
Skin Pharmacol Physiol; 2020; 33(5):270-279. PubMed ID: 33080592
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA heterogeneity in melanoma progression.
Thyagarajan A; Tsai KY; Sahu RP
Semin Cancer Biol; 2019 Dec; 59():208-220. PubMed ID: 31163254
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
Thyagarajan A; Shaban A; Sahu RP
J Pharmacol Exp Ther; 2018 Jan; 364(1):1-12. PubMed ID: 29054858
[TBL] [Abstract][Full Text] [Related]
14. New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network.
Zhou K; Liu M; Cao Y
Front Mol Biosci; 2017; 4():46. PubMed ID: 28736730
[TBL] [Abstract][Full Text] [Related]
15. Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.
Olvedy M; Tisserand JC; Luciani F; Boeckx B; Wouters J; Lopez S; Rambow F; Aibar S; Thienpont B; Barra J; Köhler C; Radaelli E; Tartare-Deckert S; Aerts S; Dubreuil P; van den Oord JJ; Lambrechts D; De Sepulveda P; Marine JC
J Clin Invest; 2017 Jun; 127(6):2310-2325. PubMed ID: 28463229
[TBL] [Abstract][Full Text] [Related]
16. Reduction of COX-2 through modulating miR-124/SPHK1 axis contributes to the antimetastatic effect of alpinumisoflavone in melanoma.
Gao M; Chang Y; Wang X; Ban C; Zhang F
Am J Transl Res; 2017; 9(3):986-998. PubMed ID: 28386327
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma.
Jiao J; Fan Y; Zhang Y
J Int Med Res; 2015 Oct; 43(5):672-8. PubMed ID: 26150475
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions.
Cappellesso R; Tinazzi A; Giurici T; Simonato F; Guzzardo V; Ventura L; Crescenzi M; Chiarelli S; Fassina A
Cancer Cytopathol; 2014 Sep; 122(9):685-93. PubMed ID: 24888238
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
